Back to Royal Bank of Canada Royal Bank of Canada

NVAXNVAX

Showing 8 of 28 quarters

Position history for Royal Bank of CanadaRoyal Bank of Canada's holdings in Novavax, Inc.

Yes. Royal Bank of Canada holds 25,759 shares of NVAX (Novavax), worth $242,000, as of its Q2 2026 13F filing. It increased the position by 12,272 shares (+91.0%) from Q1 2026. Royal Bank of Canada has held NVAX in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$242,000

Current Shares

25,759

Total Value Change

-$127,000

Total Shares Change

-3,543

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
25,759
+91.0%
$242,0000.0%$9.42
25
2026-Q1
Decreased
13,487
-13.5%
$110,0000.0%$8.14
0
2025-Q4
Decreased
15,593
-98.6%
$105,0000.0%$6.72
0
2025-Q3
Increased
1.1M
+6.2%
$9.9M0.0%$8.67
29
2025-Q2
Increased
1.1M
+7178.2%
$6.8M0.0%$6.30
44
2025-Q1
Decreased
14,801
-30.7%
$95,0000.0%$6.41
0
2024-Q4
Decreased
21,364
-27.1%
$172,0000.0%$8.04
0
2024-Q3
Increased
29,302
+23.7%
$369,0000.0%$12.63
29

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used